TXG Stock Analysis: Buy, Sell, or Hold?
TXG - 10x Genomics, Inc. Class A Common Stock
$32.94
-1.82 (-5.22%)
▼
5d:
+14.22%
30d:
+37.36%
90d:
+79.12%
HOLD
MODERATE Confidence
Analysis Updated: Jun 22, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When TXG Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: TXG trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
📊 HOLD: TXG trades at premium valuation expecting 9.0% growth. Hold existing positions but don't chase. Wait for better entry.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$7.01
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$4.35
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TXG is currently trading at $32.94, which is considered extended relative to its 30-day fair value range of $24.15 to $32.22. From a valuation perspective, the stock is trading at a premium (Forward PE: 164.7) compared to its historical average (127.2). At these levels, the market is pricing in 9.0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, TXG is in a uptrend. Immediate support is located at $23.72, while resistance sits at $35.65. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: TXG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $26.85. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TXG is in a uptrend. Immediate support is located at $23.72, while resistance sits at $35.65. Short-term momentum is weak, with the stock down 5.2% recently.
Market Sentiment: TXG has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. However, the stock is trading significantly above the average Wall Street target of $26.85. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$24.15 -
$32.22
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
46.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.2%)
- BEARISH: Trading 18.5% above Wall St target ($26.85)
- NEUTRAL: Trading at premium valuation - market expects 9.0% growth which is achievable
Trading Range Analysis
30-Day Trading Range
$24.15 -
$32.22
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$23.72
Resistance Level
$35.65
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
164.70
Wall Street Target
$26.85
(-18.5%)
Revenue Growth (YoY)
-2.6%
Profit Margin
-3.5%
Valuation Premium vs History
+9.0% premium
PE vs Historical
164.7 vs 127.2
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+9.0%
(market-implied from PE analysis)
1-Year Target
$35.90
(+9%)
2-Year Target
$39.14
(+19%)
3-Year Target
$42.66
(+30%)
3-Yr Target (if PE normalizes)
(PE: 165→127)
PE COMPRESSION
$32.95
(0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: June 23, 2026 6:04 AM ET
Data refreshes hourly during market hours. Next update: 7:04 AM
Data refreshes hourly during market hours. Next update: 7:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TXG showing a specific setup today?
Insider Activity (6 Months)
0
Buys
6
Sells
Net
INSIDERS SELLING
Recent Transactions
Serge Saxonov
SELL
5000 shares
2026-04-14
Serge Saxonov
SELL
5000 shares
2026-03-24
Serge Saxonov
SELL
10000 shares
2026-03-23
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$245 | 54 HOLD |
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 54 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 57 HOLD |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 55 HOLD |
|
WAY
Waystar Holding Corp. Co… |
STRONG BUY
13 analysts |
$34 | 55 HOLD |
